Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Nature Neuroscience
|
August 27, 2015
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
Ana Jovičić, Jerome Mertens, Steven Boeynaems, et al.
Nature Cell Biology
|
August 28, 2023
RBFOX2 recognizes N<sup>6</sup>-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Xiaoyang Dou, Yu Xiao, Chao Shen, et al.
Cancer Research
|
April 3, 2008
Origins and prevalence of the American Founder Mutation of MSH2
Mark Clendenning, Mark E Baze, Shuying Sun, et al.
Nature Communications
|
January 28, 2015
ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP
Shuying Sun, Shuo-Chien Ling, Jinsong Qiu, et al.
Cancer Research
|
December 17, 2008
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells
Huey-Jen L Lin, Tao Zuo, Ching-Hung Lin, et al.
Neuron
|
March 25, 2015
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1
Adrian Israelson, Dara Ditsworth, Shuying Sun, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
5-ethynyluridine perturbs nuclear RNA metabolism to promote the nuclear accumulation of TDP-43 and other RNA binding proteins
Lindsey R Hayes, Benjamin Zaepfel, Lauren Duan, et al.
Frontiers in Neuroscience
|
November 6, 2023
Exploring the brain epitranscriptome: perspectives from the NSAS summit
Sung-Min Lee, Bonsang Koo, Clément Carré, et al.
Neuron
|
October 8, 2019
CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation
Weiwei Cheng, Shaopeng Wang, Zhe Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration
Clotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Nature Neuroscience
|
August 27, 2015
Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
Ana Jovičić, Jerome Mertens, Steven Boeynaems, et al.
Nature Cell Biology
|
August 28, 2023
RBFOX2 recognizes N<sup>6</sup>-methyladenosine to suppress transcription and block myeloid leukaemia differentiation
Xiaoyang Dou, Yu Xiao, Chao Shen, et al.
Cancer Research
|
April 3, 2008
Origins and prevalence of the American Founder Mutation of MSH2
Mark Clendenning, Mark E Baze, Shuying Sun, et al.
Nature Communications
|
January 28, 2015
ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP
Shuying Sun, Shuo-Chien Ling, Jinsong Qiu, et al.
Cancer Research
|
December 17, 2008
Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells
Huey-Jen L Lin, Tao Zuo, Ching-Hung Lin, et al.
Neuron
|
March 25, 2015
Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1
Adrian Israelson, Dara Ditsworth, Shuying Sun, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
5-ethynyluridine perturbs nuclear RNA metabolism to promote the nuclear accumulation of TDP-43 and other RNA binding proteins
Lindsey R Hayes, Benjamin Zaepfel, Lauren Duan, et al.
Frontiers in Neuroscience
|
November 6, 2023
Exploring the brain epitranscriptome: perspectives from the NSAS summit
Sung-Min Lee, Bonsang Koo, Clément Carré, et al.
Neuron
|
October 8, 2019
CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation
Weiwei Cheng, Shaopeng Wang, Zhe Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 31, 2013
Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration
Clotilde Lagier-Tourenne, Michael Baughn, Frank Rigo, et al.
Page
of 10